Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial

BACKGROUND: Despite curative intent resection in patients with non-small cell lung cancer (NSCLC), recurrence leading to mortality remains too common. Melatonin has shown promise for the treatment of patients with lung cancer; however, its effect following cancer resection has not been studied. We e...

Descripción completa

Detalles Bibliográficos
Autores principales: Seely, Dugald, Legacy, Mark, Auer, Rebecca C., Fazekas, Anna, Delic, Edita, Anstee, Caitlin, Angka, Leonard, Kennedy, Michael A., Tai, Lee-Hwa, Zhang, Tinghua, Maziak, Donna E., Shamji, Farid M., Sundaresan, R. Sudhir, Gilbert, Sebastien, Villeneuve, P. James, Ashrafi, Ahmad S., Inculet, Richard, Yasufuku, Kazuhiro, Waddell, Thomas K., Finley, Christian, Shargall, Yaron, Plourde, Madelaine, Fergusson, Dean A., Ramsay, Tim, Seely, Andrew J.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930365/
https://www.ncbi.nlm.nih.gov/pubmed/33681747
http://dx.doi.org/10.1016/j.eclinm.2021.100763

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930365/
https://www.ncbi.nlm.nih.gov/pubmed/33681747
http://dx.doi.org/10.1016/j.eclinm.2021.100763

Ejemplares similares